Dragon Pharma Dragontropin HGH 100 IU
For athletes, bodybuilders, and fitness enthusiasts seeking to optimize recovery, muscle growth, and body composition, recombinant human growth hormone (r-hGH) represents a cornerstone of advanced anabolic research. Dragontropin HGH by Dragon Pharma is a high-purity somatropin formulation designed for research applications requiring consistent potency, purity, and reliability. This Dragontropin HGH 100 IU kit includes 10 vials of 10 IU each, providing researchers with a complete supply of premium-grade growth hormone for extended study protocols.
Somatropin is a 191-amino acid recombinant human growth hormone that mimics the action of endogenous growth hormone. It exerts its effects by binding to growth hormone receptors, stimulating the production of insulin-like growth factor-1 (IGF-1), which mediates many of its anabolic and metabolic effects. Research published in the NIH PubMed database demonstrates that r-hGH promotes protein synthesis, lipolysis, collagen synthesis, and improved recovery—making it one of the most studied compounds in exercise physiology and body composition research.
The relevance of HGH to the athletic and bodybuilding community is profound. Growth hormone plays a critical role in muscle protein synthesis, connective tissue repair, fat metabolism, and overall recovery. For bodybuilders, HGH supports lean muscle preservation during cutting phases, enhances recovery from intense training, promotes joint and tendon health, and contributes to the aesthetic appearance of muscle fullness and skin quality. The 100 IU kit format is ideal for extended research protocols, providing a consistent supply for studies lasting 10-20 weeks depending on dosing.
Quality assurance is paramount in growth hormone research. Each batch of our Dragontropin HGH 100 IU inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. Our quality control includes multiple batch tests demonstrating consistent potency: March 2026 (10.35 IU), September 2025 (11.53 IU), April 2025 (15.83 IU), October 2024 (11.79 IU), and August 2024 (12.45 IU)—exceeding label claims and demonstrating Dragon Pharma's commitment to quality. This level of transparency ensures that researchers can trust the integrity of the compounds they are investigating.
For bodybuilders and strength athletes seeking comprehensive anabolic and recovery protocols, Dragontropin HGH offers a well-characterized and extensively studied mechanism for growth hormone modulation. Whether investigating strategies for enhanced recovery, muscle preservation during caloric restriction, or connective tissue health, Dragon Pharma's Dragontropin HGH delivers the purity, potency, and reliability required for serious research into growth hormone pathways.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
Dragontropin HGH is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting each 10 IU vial with 1-2mL of bacteriostatic water. Typical research dosing ranges from 2-10 IU per day, often administered subcutaneously or intramuscularly. Dosing frequency and timing vary based on research objectives, with common protocols including daily administration, often in the evening or post-workout. It is recommended to store reconstituted solution in a refrigerator (2-8°C) and use within 28 days. Each kit contains 10 vials, sufficient for extended research protocols.
For researchers investigating comprehensive anabolic and recovery protocols, combining HGH with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- IGF-1 LR3: An insulin-like growth factor that mediates many of HGH's anabolic effects for complementary research.
- MK 677: An oral growth hormone secretagogue for comparative research on endogenous vs. exogenous GH elevation.
- T3: A thyroid hormone studied alongside HGH for metabolic optimization research.